Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Topical Combination Agent for Plaque Psoriasis Showed Superiority to Monotherapies in PIII Trial: Maruho
November 19, 2014
- Giotrif Extends Overall Survival in Japanese NSCLC Patients with Del19 EGFR Mutation: NBI
November 19, 2014
- Valtrex Adult Indications Approved for Children: GSK
November 19, 2014
- Inderal Tablets Approved for Prevention of Hypoxic Episodes: AZ
November 19, 2014
- RaQualia’s Acid Pump Antagonist Enters Domestic PI Study
November 18, 2014
- Diet and Exercise Regimens Weigh on Type 2 Diabetes Patients: MSD Poll
November 18, 2014
- Otsuka Holdings Logs Double-Digit Sales, Profit Rise on Abilify in April-September
November 14, 2014
- Combined Half-Year Sales of Major Japanese Drug Makers Up 2.8% Thanks to Overseas Sales
November 14, 2014
- Gene Techno Science Forms Capital Tie-Up with ORTHOREBIRTH to Codevelop, Market Synthetic Bone
November 14, 2014
- Mediceo Initiates Full-Scale Contract PMS Business to Collect Data from GPs
November 14, 2014
- MTPC Files Radicut for Amyotrophic Lateral Sclerosis
November 14, 2014
- Santen Partners with Singapore Eye Research Institute for Development of New Ophthalmic Drugs
November 14, 2014
- CSO Apo Plus Eyes 700 Contract Sales Reps by March 2016
November 14, 2014
- Nihon Chouzai Eyes Scaling Up Production Capacity
November 13, 2014
- Japan Pharma Market Levels Off in July-September: IMS
November 13, 2014
- 90 Pharma Companies Join Forces to Reduce CO2 Emissions; Aiming at 23% Reduction by FY2020
November 13, 2014
- CMIC Holdings, UDG Healthcare Collaborate in CSO, CMO Businesses
November 13, 2014
- Avigan Could Clinch Overseas Approval for Ebola Early Next Year: Fujifilm Official
November 13, 2014
- Fujifilm Sees Healthcare as Growth Engine in Next 3 Years, yet No New Drug Debut until FY2018
November 12, 2014
- Generic Makers Back on Growth Track in First Half of FY2014
November 12, 2014
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…